Sawi, Ariana .
HRN: 13-74-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
06/21/2023
06/23/2023
PO
5mL
BID
Ascaris
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes